Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001029
Filing Date
2025-01-07
Accepted
2025-01-07 17:20:37
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 form4-01072025_050130.html 4  
1 form4-01072025_050130.xml 4 5782
  Complete submission text file 0001415889-25-001029.txt   7320
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GRAPHITE BIO, INC. 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address
Young Alethia (Reporting) CIK: 0001918147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 25515780